GPT Healthcare Limited IPO
₹177 - ₹186
80
8.52
| Open Date: | 22-Feb-2024 |
| Close Date: | 26-Feb-2024 |
| Allotment Date: | 27-Feb-2024 |
| Listing Date: | 29-Feb-2024 |
| Listing Price: | N/A |
| Face Value: | ₹10 Per Equity Share |
| Issue Price: | ₹177-186 Per Equity Share |
| Issue Size: | Total Issue Size 28,233,323 shares (aggregating up to ₹525.14 Cr) : Fresh Issue 2,150,537 shares (aggregating up to ₹40.00 Cr) : Offer for Sale 26,082,786 shares of ₹10 (aggregating up to ₹485.14 Cr) |
| Market Lot (Min Amount): | Retail - ₹14,880 : S-HNI - ₹208,320 : B-HNI - ₹1,011,840 |
As on | QIB | Nll | Rll | Total |
|---|---|---|---|---|
| Shares Offered/Reserved | 5,646,665 | 4,234,999 | 9,881,663 | 19,763,327 |
| Day 1 - 22-02-24 05:00 PM | 0.00x | 0.18x | 0.68x | 0.38x |
| Day 2 - 23-02-24 05:00 PM | 0.19x | 0.80x | 1.26x | 0.85x |
| Day 3 - 26-02-24 05:00 PM | 17.30x | 11.02x | 2.44x | 8.52x |
| Total No. of Application: | 258,361 (Approx.) | |||
| Retail Subscription on the basis of Apps: | 2.09x | |||
| Earning Per Share(EPS) | ₹4.88/- |
| P/E Ratio | 38.1 |
| RoNW | 23.77% |
| Net Asset Value (NAV) - Post Issue: | ₹20.54/- |
| Total Assets | Total Revenue | Profit After Tax | |
|---|---|---|---|
| 31 Sep,2023 | 332.09 | 206.70 | 23.49 |
| 31 Mar,2023 | 326.76 | 366.73 | 39.01 |
| 31 Mar,2022 | 323.22 | 342.40 | 41.66 |
| 31 Mar,2021 | 317.21 | 248.86 | 21.09 |
| Pre Issue Share Holding | 67.34% |
| Post Issue Share Holding | N/A% |
| 1. GPT Sons Private Limited |
| 2. Dwarika Prasad Tantia |
| 3. Dr. Om Tantia |
| 4. Shree Gopal Tantia |
The company proposes to utilize the Net Proceeds towards funding the following objects:
- Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company from banks and financial institutions; and
- General corporate purposes.
Incorporated in 1989, GPT Healthcare Limited operates a chain of mid-sized, multi-specialty, full-service hospitals in Eastern India under the ILS Hospitals brand, providing integrated healthcare services focusing on secondary and tertiary care.
Based in Kolkata, West Bengal, the company offers a range of healthcare services in over 35 specialties and super-specialties, including internal medicine and diabetology, nephrology (including kidney transplant), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. It also offers integrated diagnostic services and pharmacies.
GPT Healthcare's hospitals are located in four cities, namely
- Salt Lake, Kolkata (West Bengal) with a capacity of 85 beds, including 17 beds in various ICUs and HDUs (as of June 30, 2023)
- Agartala (Tripura) with a capacity of 205 beds (as of June 30, 2023), including 66 beds in various ICUs and HDUs
- Dum Dum, Kolkata (West Bengal) with a capacity of 155 beds, including 53 beds in various ICUs and HDUs as of June 30, 2023
- Howrah (West Bengal) with a capacity of 116 beds, including 43 beds in various ICUs and HDUs, as of June 30, 2023.
As at June 30, 2023, the company operates four multidisciplinary hospitals with a total capacity of 561 beds, offering a comprehensive range of healthcare services in over 35 specialties and super-specialties.
As at June 30, 2023, the company had 1,855 employees, 85 full-time consultants, and 465 visiting consultants.
No financial information whatsoever published anywhere, within this application, should be considered as an advise to buy or sell securities or invest in IPOs, or as guide to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
Also we are not a SEBi registered analyst comapny. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this application. Above information is based on information available as on date coupled with market perceptions.
If you are agree with app tems and condition to use the app.
Thank you.